Abnormal lysosomal trafficking and enhanced exosomal export of cisplatin in drug-resistant human ovarian carcinoma cells
- 1 October 2005
- journal article
- Published by American Association for Cancer Research (AACR) in Molecular Cancer Therapeutics
- Vol. 4 (10), 1595-1604
- https://doi.org/10.1158/1535-7163.mct-05-0102
Abstract
Previous work has shown that cisplatin (CDDP) becomes concentrated in lysosomes, and that acquired resistance to CDDP is associated with abnormalities of protein trafficking and secretion. The lysosomal compartment in CDDP-sensitive 2008 human ovarian carcinoma cells was compared with that in CDDP-resistant 2008/C13*5.25 subline using deconvoluting imaging and specific dyes and antibodies. The lysosomal compartment in CDDP-resistant cells was reduced to just 40% of that in the parental CDDP-sensitive cells (P < 0.002). This was accompanied by a reduced expression of the lysosome-associated proteins 1 and 2 (LAMP1 and LAMP2) as determined by both microscopy and Western blot analysis. The CDDP-resistant cells released more protein as exosomes and Western blot analysis revealed that these exosomes contained substantially more LAMP1 than those released by the CDDP-sensitive cells. Following loading of the whole cell with CDDP, the exosomes released from 2008/C13*5.25 cells contained 2.6-fold more platinum than those released from sensitive cells. Enhanced exosomal export was accompanied by higher exosomal levels of the putative CDDP export transporters MRP2, ATP7A, and ATP7B. Expression profiling identified significant increases in the expression of several genes whose products function in membrane fusion and vesicle trafficking. This study shows that the lysosomal compartment of human ovarian carcinoma cells selected for stable resistance to CDDP is markedly reduced in size, and that these cells abnormally sort some lysosomal proteins and the putative CDDP transporters into an exosomal pathway that also exports CDDP.Keywords
This publication has 41 references indexed in Scilit:
- The Wilson Disease Protein ATP7B Resides in the Late Endosomes with Rab7 and the Niemann-Pick C1 ProteinThe American Journal of Pathology, 2005
- Copper transporters regulate the cellular pharmacology and sensitivity to Pt drugsCritical Reviews in Oncology/Hematology, 2005
- The role of copper transporters in the development of resistance to Pt drugsJournal of Inorganic Biochemistry, 2004
- cDNA microarray-based identification of genes and pathways associated with oxaliplatin resistanceCancer Chemotherapy and Pharmacology, 2004
- Confocal Microscopic Analysis of the Interaction between Cisplatin and the Copper Transporter ATP7B in Human Ovarian Carcinoma CellsClinical Cancer Research, 2004
- Gastrointestinal and Systemic Uptake of Bismuth in Mice after Oral ExposureBasic & Clinical Pharmacology & Toxicology, 2003
- The Copper Export Pump ATP7B Modulates the Cellular Pharmacology of Carboplatin in Ovarian Carcinoma CellsMolecular Pharmacology, 2003
- Enhanced Cell Killing by Overexpression of Dominant-negative Phosphatidylinositol 3-Kinase Subunit, Δp85, Following Genotoxic StressesJapanese Journal of Cancer Research, 2000
- Progression of subcellular changes during chemical hypoxia to cultured rat hepatocytes: A laser scanning confocal microscopic studyHepatology, 1995
- X-Ray Microanalysis and Ion Microscopy of Guinea Pig Cochlea and Kidney after Cisplatin TreatmentORL, 1994